First potential Lassa fever vaccine set for trial by year’s end

Scientists are rushing to find a vaccine for Lassa fever, and their efforts may have borne fruit in the form of a measles-platform-based concoction that they now intend to put through human clinical trials by the end of the year. Lassa, which infects up to 300,000 people per year and kills between 5,000 and 6,000, is a hemorrhagic fever endemic to West Africa.
Read more...

;